Trip therapy news
Latest news: Studies on psilocybin are now ongoing and investigating effectiveness in Alcoholism (AUD, alcohol use disorder), Smoking addiction, Opioid addiction, Major depression (Depressive disorder Major),
therapy-resistant depression, Anxiety symptoms, Obsessive-Compulsive Disorder (OCD), Body Dysmorphic Disorders (BDD), Anorexia, Alzheimer's, Parkinson's, Migraine, Cluster headache
